Company Filing History:
Years Active: 2006
Title: Innovations by Hang Chen in Tyrosine Kinase Inhibition
Introduction
Hang Chen is an accomplished inventor based in Waterbury, CT (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as tyrosine kinase inhibitors. Her work is crucial in addressing various medical conditions related to tyrosine kinase-mediated disorders.
Latest Patents
Hang Chen holds a patent for "Fused quinazoline derivatives useful as tyrosine kinase inhibitors." This invention is directed to a compound characterized by a specific structure that includes a 7–18 membered ring with various heteroatoms. The patent outlines the potential of these compounds in treating patients suffering from disorders mediated by tyrosine kinases. The invention also includes pharmaceutical compositions comprising the compound and methods for their application in medical treatments.
Career Highlights
Hang Chen is currently associated with Beta Pharma, Inc., where she continues to innovate and develop new pharmaceutical solutions. Her expertise in the field has led to advancements that could significantly impact patient care and treatment options.
Collaborations
Hang Chen collaborates with notable colleagues, including Don Zhang and Guojian Xie. These partnerships enhance her research and development efforts, fostering an environment of innovation and discovery.
Conclusion
Hang Chen's contributions to the field of pharmaceuticals, particularly through her patent on tyrosine kinase inhibitors, highlight her role as a leading inventor. Her work at Beta Pharma, Inc. and collaborations with esteemed colleagues further underscore her commitment to advancing medical science.